Amarin Corp Plc\Uk AMRN
NASDAQ AMRN
$12.72 -0.28 (-2.15%)
At close: Oct 1, 2026 · 4:00 PM EDT

Amarin Corp Plc\Uk (AMRN) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Amarin Corp Plc\Uk (AMRN) recorded Liabilities and Shareholders Equity of $624.4 million in Q2 2026, down 6.8% from $670.13 million a year earlier and down 3.3% from the prior quarter.

Analysis

Amarin Corp Plc\Uk (AMRN) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Amarin Corp Plc\Uk reported Liabilities and Shareholders Equity of $670.78 million, down 2.1% from FY2024.

  • Annual Liabilities and Shareholders Equity has declined for four straight years, with a five-year compound annual growth rate of -7.0% (FY2020 to FY2025).
  • Across earlier years, Liabilities and Shareholders Equity came in at $685.35 million in FY2024 (-17.6%), $831.68 million in FY2023 (-6.1%), $886.18 million in FY2022 (-17.0%) and $1.07 billion in FY2021 (+10.6%).
  • The Q2 2026 figure is the lowest quarterly Liabilities and Shareholders Equity since Q2 2019.
  • On a year-over-year basis, Liabilities and Shareholders Equity has declined for 18 consecutive quarters, with an average decline of 10.5% over the last eight quarters.
  • Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 10.6% in Q4 2021, against a decline of 17.6% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $645.8 million (Q1 2026), $670.78 million (Q4 2025) and $659.81 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Amarin Corp Plc\Uk 5.46 Bn 4.25 Bn 14.99 Mn 624.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 624.40 Mn
Mar 31, 2026 645.80 Mn
Dec 31, 2025 670.78 Mn
Sep 30, 2025 659.81 Mn
Jun 30, 2025 670.13 Mn
Mar 31, 2025 655.70 Mn
Dec 31, 2024 685.35 Mn
Sep 30, 2024 750.62 Mn
Jun 30, 2024 799.90 Mn
Mar 31, 2024 790.01 Mn
Dec 31, 2023 831.68 Mn
Sep 30, 2023 839.03 Mn
Jun 30, 2023 860.02 Mn
Mar 31, 2023 860.20 Mn
Dec 31, 2022 886.18 Mn
Sep 30, 2022 908.30 Mn
Jun 30, 2022 973.24 Mn
Mar 31, 2022 973.71 Mn
Dec 31, 2021 1.07 Bn
Sep 30, 2021 1.04 Bn
API Access

Amarin Corp Plc\Uk Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=AMRN&period=max&api_key=YOUR_API_KEY